Trial Profile
Concurrent Chemoradiation With Concomitant Boost In Locally Advanced Rectal Cancer: A Phase II Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Mar 2021
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary) ; Raltitrexed (Primary)
- Indications Rectal cancer
- Focus Therapeutic Use
- 01 Aug 2016 Results published in the Anticancer Research
- 05 Apr 2016 New trial record